Portola Capital Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 2
- Investments
- 2
- Exits
- 2
Portola Capital Partners General Information
Description
Portola Capital Partners is a healthcare investment and advisory firm that focuses on innovation, growth and cross-border deals in North America, Asia, Europe and emerging markets. The firm also focuses on investing in emerging public and private biotechnology and device companies.
Contact Information
Website
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 450 Lexington Avenue
- Suite 39B
- New York, NY 10017
- United States
Portola Capital Partners Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aptinyx | 15-Sep-2015 | Seed Round | Drug Discovery | Generating Revenue/Not Profitable | ||
| 000000 | 02-Dec-2014 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 |
Portola Capital Partners Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Aptinyx | 21-Jun-2018 | IPO | 00000 |
| 000000 | 28-Aug-2015 | 000000000000000000 | 00.000 |
Portola Capital Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialPortola Capital Partners Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Sasha Blaug Ph.D | Senior Investment Analyst & Vice President | New York, NY |